GENTANX Trademark

Trademark Overview

On Monday, October 23, 2023, a trademark application was filed for GENTANX with the United States Patent and Trademark Office. The USPTO has given the GENTANX trademark a serial number of 98236458. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 26, 2025. This trademark is owned by Outbreaks, Inc.. The GENTANX trademark is filed in the Pharmaceutical Products category with the following description:

Homeopathic pharmaceuticals for use in the treatment of cold sores, and fever blisters
gentanx

General Information

Serial Number98236458
Word MarkGENTANX
Filing DateMonday, October 23, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements

Goods and ServicesHomeopathic pharmaceuticals for use in the treatment of cold sores, and fever blisters

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOutbreaks, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCary, NC 27511
Party NameOutbreaks, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCary, NC 27511

Trademark Events

Event DateEvent Description
Wednesday, January 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Monday, October 23, 2023NEW APPLICATION ENTERED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 23, 2024SOU EXTENSION 1 FILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 3, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 3, 2024PETITION TO REVIVE-GRANTED
Tuesday, December 3, 2024NOTICE OF REVIVAL - E-MAILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 3, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, February 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 21, 2025SOU EXTENSION 1 GRANTED
Wednesday, April 9, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 9, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 23, 2025WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, April 23, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, May 26, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, May 26, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, February 21, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

gentanx fever blisters sores cold pharmaceuticals treatment homeopathic